Stephanie Korn

11.0k total citations · 7 hit papers
133 papers, 6.5k citations indexed

About

Stephanie Korn is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Stephanie Korn has authored 133 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Physiology, 81 papers in Pulmonary and Respiratory Medicine and 25 papers in Immunology and Allergy. Recurrent topics in Stephanie Korn's work include Asthma and respiratory diseases (114 papers), Respiratory and Cough-Related Research (52 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (33 papers). Stephanie Korn is often cited by papers focused on Asthma and respiratory diseases (114 papers), Respiratory and Cough-Related Research (52 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (33 papers). Stephanie Korn collaborates with scholars based in Germany, United States and United Kingdom. Stephanie Korn's co-authors include Eugene R. Bleecker, Roland Buhl, Pascal Chanez, Ian Pavord, Peter Howarth, Oliver N. Keene, Héctor Ortega, Guy Brusselle, Marek Lommatzsch and Roland Buhl and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Stephanie Korn

116 papers receiving 6.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

2012 1.6k citations Ian Pavord, Stephanie Korn et al. profile →
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

2016 984 citations Stephanie Korn, Marek Lommatzsch et al. profile →
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

2015 840 citations Michael E. Wechsler, Guy Brusselle et al. The Lancet Respiratory Medicine profile →
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

2017 384 citations Ian Pavord, Pascal Chanez et al. New England Journal of Medicine profile →
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials

2023 95 citations Jonathan Corren, Andrew Menzies‐Gow et al. profile →
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype

2024 47 citations David J. Jackson, Michael E. Wechsler et al. New England Journal of Medicine profile →
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype

2025 22 citations Frank C. Sciurba, Alberto Papi et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Stephanie Korn

Since Specialization

Citations

This map shows the geographic impact of Stephanie Korn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Korn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Korn more than expected).

Fields of papers citing papers by Stephanie Korn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Korn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Korn. The network helps show where Stephanie Korn may publish in the future.

Co-authorship network of co-authors of Stephanie Korn

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Korn. A scholar is included among the top collaborators of Stephanie Korn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Korn. Stephanie Korn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial 2025 ·The Lancet Respiratory Medicine ·David J. Jackson, Njira Lugogo, (unknown), Liam G. Heaney, Stephanie Korn, Guy Brusselle, Pascal Chanez, (unknown), Jean‐Pierre Llanos, (unknown), Kinga Sałapa, Bill Cook, Amit Parulekar, (unknown), Robert Fogel, Neil A. Martin, Shamir Chandarana	0
2	Real-world outcomes after 2 years of dupilumab therapy for severe asthma: the ProVENT study 2025 ·Marek Lommatzsch, Stephanie Korn, Olaf Schmidt, Hartmut Timmermann, Monika Gappa, Henrik Watz, Xavier Soler, (unknown), (unknown), Michael Hahn, (unknown)	0
3	Late Breaking Abstract - Dupilumab reduces the risk of severe exacerbations in patients with chronic obstructive pulmonary disease: results from BOREAS and NOTUS 2025 ·Surya P. Bhatt, Imran Satia, A. Anzueto, Jean Bourbeau, Alberto Papi, Stephanie Korn, Fernando J. Martinez, Gaëtan Deslée, Changming Xia, (unknown), Mena Soliman, (unknown)	0
4	Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction 2025 ·Clinical & Experimental Allergy ·Renaud Louis, Marek Lommatzsch, David J. Jackson, Andrew Menzies‐Gow, Anat Shavit, David Cohen, Flavia Hoyte, Stephanie Korn	2
5	Benralizumab-Induced Asthma Remission: Impact of Different Tools and Thresholds to Define Good Asthma Control 2025 ·Respiration ·Marek Lommatzsch, Henrik Watz, (unknown), (unknown), (unknown), Stephanie Korn	1
6	Impact of Smoking on Biological Treatment Response in Patients From the German Severe Asthma (GAN) Registry 2025 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), (unknown), Andreas Renner, (unknown), (unknown), Christoph Krall, Katrin Milger, Christian Schulz, Margret Jandl, Rainer Ehmann, Olaf Schmidt, Roland Buhl, Eckard Hamelmann, Christian Taube, Stephanie Korn, (unknown), Marco Idzko	1
7	Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ) 2024 ·Pneumologie ·Frank Kanniess, (unknown), Marek Lommatzsch, Thomas Schultz, Hartmut Timmermann, Olaf Schmidt, (unknown), Hans Jörg Baumann, Roland Buhl, Christian Taube, (unknown), Stephanie Korn	1
8	Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype breakdown → 2024 ·New England Journal of Medicine ·David J. Jackson, Michael E. Wechsler, Daniel J. Jackson, David I. Bernstein, Stephanie Korn, Paul Pfeffer, Ruchong Chen, Junpei Saito, (unknown), (unknown), Loretta Jacques, (unknown), Stein Schalkwijk, Douglas G. Smith, Peter Howarth, Ian Pavord	47
9	Efficacy of Mepolizumab in Patients With Chronic Obstructive Pulmonary Disease With or Without Chronic Bronchitis: Post Hoc Analysis of the METREX and METREO Phase 3 Trials 2024 ·Frank C. Sciurba, (unknown), Stephanie Korn, Mona Bafadhel, (unknown), (unknown), Àlvar Agustí, Bhabita Mayer	0
10	German Asthma Net – Was haben wir bisher gelernt? 2023 ·(unknown), Roland Buhl, Eckard Hamelmann, Marco Idzko, Christian Taube, Stephanie Korn	0
11	Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study) 2023 ·Journal of Asthma and Allergy ·Stephanie Korn, Katrin Milger, Dirk Skowasch, Christian Schulz, (unknown), (unknown), (unknown), Michael Hennig, Roland Buhl	7
12	Tezepelumab in patients with allergic and eosinophilic asthma 2023 ·Allergy ·(unknown), Roland Buhl, Jonathan Corren, Nicola A. Hanania, Harold Kim, Stephanie Korn, Marek Lommatzsch, Neil Martin, (unknown), Shuaib Nasser, Ian Pavord, Christian Domingo	19
13	Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma 2023 ·European Respiratory Journal ·Gail M. Gauvreau, Jens M. Hohlfeld, J. Mark FitzGerald, Louis‐Philippe Boulet, Donald W. Cockcroft, Beth E. Davis, Stephanie Korn, Oliver Kornmann, Richard Leigh, Irvin Mayers, Henrik Watz, Sarah Schmidt Grant, Monish Jain, Maciej Cabanski, Peter Pertel, Ieuan Jones, (unknown), Hui Cao, Paul M. O’Byrne	40
14	Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) 2020 ·SHILAP Revista de lepidopterología ·(unknown), Tobias Welte, (unknown), Stephanie Korn, Margret Jandl, (unknown), (unknown), Peter Barker, (unknown), (unknown)	1
15	<p>Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma</p> 2020 ·Journal of Asthma and Allergy ·Nora Drick, Katrin Milger, Benjamin Seeliger, Jan Fuge, Stephanie Korn, Roland Buhl, Maren Schuhmann, Felix Herth, Benjamin Kendziora, Jürgen Behr, Nikolaus Kneidinger, Karl‐Christian Bergmann, Christian Taube, Tobias Welte, Hendrik Suhling	34
16	Evaluation of the Efficacy and Safety of Two Doses of Aclidinium and Formoterol in Fixed-Dose Combination in Patients With COPD: The ACLIFORM Study 2014 ·CHEST Journal ·Dave Singh, Paul Jones, Eric Bateman, Stephanie Korn, Cristina Helena dos Reis Serra, Eduard Molins, Cynthia Caracta, Esther García Gil, Anne Leselbaum	7
17	COPD and the asthma-COPD-overlap-syndrome 2014 ·European Respiratory Journal ·(unknown), Stephanie Korn, (unknown), Roland Buhl	1
18	Therapiestrategien bei Asthma 2012 ·Der Internist ·Stephanie Korn, Christian Taube, Roland Buhl	3
19	Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions 2005 ·Respiratory Medicine ·Stephanie Korn, Jutta Beier, (unknown), Oliver Kornmann, Roland Buhl, Kai Michael Beeh	9
20	Experiences of a parent support group with the long-term consequences of esophageal atresia 2001 ·Journal of Pediatric Surgery ·Felix Schier, Stephanie Korn, (unknown)	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact